Results 61 to 70 of about 14,309 (181)
Acta Gastroenterológica Latinoamericana, 2009 Introducción. El tratamiento recomendado para los pacientes con hepatitis B crónica HBeAg positivo es PEG interferón alfa 2a durante 48 semanas. No hay suficientes datos que avalen mejor respuesta con 48 semanas de tratamiento versus 24 semanas.
Joaquín Solari +9 more
doaj
Креативная хирургия и онкология, 2019 Introduction. Despite the fact that the combined use of bevacizumab and interferon α -2A has been studied extensively and proved to be safe, there will always remain a group of patients for whom continuing the long-term drug treatment after a radical ...
K. Sh. Gantsev, A. A. Khmelevskiy
doaj +1 more source
Brazilian Journal of Infectious DiseasesChronic hepatitis C is often a progressive, fibrotic disease that can lead to cirrhosis and other complications. The recommended therapy is a combination of interferon and ribavirin.
Kleber Prado +3 more
doaj +1 more source
Annals of Hepatology, 2012 Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients ...
Mario G. Pessôa +12 more
doaj +1 more source
Annals of Hepatology, 2010 There are no well established treatment guidelines about acute hepatitis C (AHC), leaving physicians to make several challenging decisions, such whether to treat, when to treat and what treatment regimens to use.
Paulo Roberto Lerias de Almeida
doaj +1 more source
Journal of Infection in Developing Countries, 2011 Interferon alpha is a molecule frequently used in the treatment of chronic hepatitis B, C, and D, with immunomodulatory and antiviral activity. It is also used in some cancer types. It has been widely claimed that interferon alpha triggers autoimmunity,
Sukran Kose +3 more
doaj +1 more source
Drug Design, Development and Therapy, 2014 Izumi Sato,1 Takuro Shimbo,2 Yohei Kawasaki,3 Naohiko Masaki41Department of Clinical Study and Informatics, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan; 2Ohta Nishinouchi Hospital, Fukushima, Japan ...
Sato I, Shimbo T, Kawasaki Y, Masaki N
doaj
Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis. [PDF]
Virol J, 2023 Shafiee A +8 more
europepmc +1 more source
Pakistan Armed Forces Medical Journal, 2009 Objective: To compare the response to Interferon Alfa (IFN) and Ribavirin (RBV) combination therapy in patients of chronic HCV infection with fibrosis stage 1 (F1) & stage 2 (F2) with fibrosis stage 3 (F3) & stage 4 (F4).
Nauman Kashif +2 more
doaj +2 more sources
Acta Médica Peruana, 2018 Introducción: bexaroteno es un rexinoide aprobado en el tratamiento de estadios tempranos y avanzados del linfoma cutáneo de células T (LCCT). Caso Clínico: el presente reporte de casos mostramos los resultados del empleo de bexaroteno en dosis bajas ...
Brady Beltrán Gárate +7 more
doaj